Trials / Completed

CompletedNCT02796716

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

Rapid Microbiological Diagnostics for MDRO Quantitative Identification and Resistance Phenotyping to Guide Antibiotic Selection in Wounded Warriors and Veterans - Task 3

Status: Completed
Phase: —
Study type: Observational
Enrollment: 2,102 (actual)

Sponsor: Denver Health and Hospital Authority · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This research will test a new ultra-rapid technology (called ID/AST Accelerate system) that uses a digital microscope to identify bacteria based on their growth patterns. This method does not have to wait for bacteria to grow in a lab. The new method can identify the type of bacteria within 2 hours of receiving a specimen. The new method also shows the effect of selected antibiotics on the bacteria including multidrug resistant bacteria so that doctors know within 6 hours from specimen collection which antibiotic kills the bacteria. To check the accuracy, speed and impact of the new method on antibiotic prescribing, investigators are proposing a study with two parts; The first part will test the accuracy and speed of the results obtained by the new method. The second part will test if having the results from the new method early would change the antibiotics prescribed to a patient in a simulation experiment. An independent infectious disease physician will be shown the results from the new method and asked if the results were accurate, would it change the antibiotic treatment for the patient.

Conditions

Interventions

Type	Name	Description
DEVICE	Testing on new technology called Accelerate ID/AST system

Timeline

Start date: 2015-07-01
Primary completion: 2016-12-01
Completion: 2016-12-01
First posted: 2016-06-13
Last updated: 2017-02-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02796716. Inclusion in this directory is not an endorsement.